Data Integrity 483’s / Warning Letters

US FDA Surprise Inspections … •Until now, FDA’s inspections of Indian pharma plants have always been with prior notice. •The surprise checks and aggressive surveillance are being considered because of “instances of fabrication of documents and human errors”. •India’s growing importance as a hub of Generic producers and rising

  Letter, Warnings, 483 s warning letters